We argue that following G-CSF treatment, MPO antibodies were formed leading to signs and symptoms of ANCA vasculitis correlating to a Birmingham vasculitis activity score (BVAS) of 18 ‘new’ points. The gene discussed is MPO; the disease is vasculitis.